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ABSTRACT 24 
Necroptosis, a regulated form of necrotic cell death requires the activation of the 25 
RIP3 kinase. Here, we identify that infection of host cells with reovirus can result 26 
in necroptosis. We find that necroptosis requires sensing of the genomic RNA 27 
within incoming virus particles via cytoplasmic RNA sensors to produce type I 28 
IFN. While these events that occur prior to de novo synthesis of viral RNA are 29 
required for induction of necroptosis, they are not sufficient. Induction of 30 
necroptosis also requires late stages of reovirus infection. Specifically, efficient 31 
synthesis of dsRNA within infected cells is required for necroptosis. These data 32 
indicate that viral RNA interfaces with host components at two different stages of 33 
infection to induce necroptosis. This work provides new molecular details about 34 
events in the viral replication cycle that contribute to the induction of necroptosis 35 
following infection with an RNA virus.  36 
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IMPORTANCE 37 
An appreciation of how cell death pathways are regulated following viral infection 38 
may reveal strategies to limit tissue destruction and prevent the onset of disease. 39 
Cell death following virus infection can occur by apoptosis or a regulated form of 40 
necrosis, known as necroptosis. Apoptotic cells are typically disposed of without 41 
activating the immune system. In contrast, necroptotic cells alert the immune 42 
system, resulting in inflammation and tissue damage. While apoptosis following 43 
virus infection has been extensively investigated, how necroptosis is unleashed 44 
following virus infection is only understood for a small group of viruses. Here, 45 
using mammalian reovirus, we highlight the molecular mechanism by which 46 
infection with a dsRNA virus results in necroptosis.   47 
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INTRODUCTION 48 
Host cell death is a common outcome of virus infection (1). One form of 49 
cell death, necroptosis, has been described following infection with influenza A 50 
virus (IAV), herpes simplex virus 1 and 2 (HSV1 or 2), murine cytomegalovirus 51 
(MCMV), and vaccinia virus (VV). In each of these cases, necroptosis protects 52 
the infected animal (2-7). Examples also exist where increased necroptosis 53 
contributes to tissue injury and exacerbates viral disease (7, 8). The impact of 54 
necroptosis on these viral diseases may be due to premature death of the 55 
infected cell or as a consequence of inflammation induced by leakage of 56 
molecules from necrotic cells (9, 10).  57 
 58 
Necroptosis requires the activation of receptor interacting protein 3 (RIP3) 59 
kinase (6, 11, 12). Once activated, RIP3 kinase signals via the pseudokinase, 60 
mixed lineage kinase-like (MLKL) protein to promote a necrotic form of cell death 61 
that is characterized by loss of membrane integrity and leakage of cellular 62 
contents (13-23). RIP3 contains a receptor-interacting protein homotypic 63 
interacting motif (RHIM) and is activated via interactions with other cellular RHIM-64 
containing proteins - TRIF (TIR-domain-containing adapter-inducing interferon-β), 65 
RIP1, or DAI (DNA-dependent activator of IFN-regulatory factors) (24). TRIF 66 
activation by Toll-like receptor 3 (TLR3) and TLR4 ligands can evoke necroptosis 67 
but necroptosis by this mechanism has not yet been demonstrated following virus 68 
infection (25, 26). RIP1 activation by tumor necrosis factor α (TNFα) induces 69 
RIP3-dependent necroptosis following VV infection (6). The pathogen sensor, 70 
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DAI is required for necroptosis in cells infected with a MCMV variant (5). 71 
Ribonucleotide reductases, ICP6 and ICP10, respectively encoded by HSV1 and 72 
HSV2 contain a RHIM-like domain. These ribonucleotide reductases interact with 73 
murine RIP1 and RIP3, promote RIP1-RIP3 or RIP3-RIP3 oligomerization, and 74 
induce necroptosis (2, 3).  75 
 76 
In contrast to these studies on DNA viruses, mechanisms by which RNA 77 
viruses induce necroptosis are less understood. IAV induces necroptosis in the 78 
lungs of cIAP2-deficient mice (8). Because uninfected cells also undergo cell 79 
death in this model, it is thought that cell death is a consequence of alteration in 80 
cellular homeostasis rather than induced by viral replication events. In wild-type 81 
cells, IAV activates a RIP3-containing signaling platform that can induce either 82 
apoptosis or necroptosis (7).  Recent evidence suggests that DAI, which was 83 
previously thought to be a sensor for cytoplasmic DNA interacts with IAV 84 
components to engage RIP3 and induce necroptosis (27, 28). RNA viruses such 85 
as Coxsackievirus B (CVB), coronavirus, mammalian reovirus (Reovirus), 86 
Theiler’s murine encephalomyelitis virus (TMEV), and West Nile virus (WNV) 87 
also have been demonstrated to evoke cell death with morphologic features 88 
resembling necrosis (29-32). However, the events in viral replication that initiate 89 
pronecrotic signaling pathways have not been defined for these RNA viruses.   90 
 91 
In this study, we investigated the mechanism by which reovirus infection 92 
culminates in necroptosis. Our results indicate that IFNβ produced by detection 93 
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of genomic RNA of incoming virus particles is required, but not sufficient for 94 
eliciting necroptosis. In addition to IFNβ expression, de novo synthesis of viral 95 
dsRNA is also required for necroptosis induction. These results suggest that 96 
detection of viral components at two distinct stages is required for the induction 97 
of necroptosis following infection with an RNA virus.  98 
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MATERIAL AND METHODS 99 
Cells and viruses. Spinner-adapted L929 cells (obtained from Dr. T. Dermody’s 100 
laboratory) were maintained in Joklik’s MEM (Lonza) supplemented to contain 101 
5% FBS, 2 mM L-glutamine, 100 U/ml of penicillin, 100 µg/mL streptomycin, and 102 
25 ng/mL of amphotericin B. Spinner-adapted L929 cells were used for 103 
cultivating and purifying viruses and for plaque assays. Prototype reovirus strain 104 
T3D was regenerated by plasmid based reverse genetics (33, 34). Viral particles 105 
were purified by Vertrel XF-extraction and CsCl gradient centrifugation (35). Viral 106 
titer was determined by plaque assay using spinner-adapted L929 cells (36). UV-107 
inactivated virus was generated using a UV cross-linker (CL-1000 UV 108 
Crosslinker; UVP). Virus diluted in PBS was placed in a 60-mm tissue culture 109 
dish and irradiated with short-wave (254-nm) UV on ice at a distance of 10 cm for 110 
1 min at 120,000 µJ/cm2. Murine L929 cells (ATCC CCL-1) were maintained in 111 
Eagle’s MEM (Lonza) supplemented with 10% fetal bovine serum (FBS), and 2 112 
mM L-glutamine. ATCC L929 cells were used for all experiments to assess cell 113 
death, viral RNA and protein synthesis, and cell signaling. Distinct from some 114 
L929 cell lines, the ATCC L929 cells used for this study do not undergo TNFα or 115 
zVAD-mediated cell death (37, 38). Wild-type and mutant bone marrow derived 116 
macrophages were obtained from Drs. Edward Mocarski and Mehul Suthar 117 
(Emory University) and were maintained in DMEM with 20% FBS, 10% filtered 118 
conditioned medium from L929 cells, 2 mM L-glutamine, 100 U/ml of penicillin, 119 
and 100 µg/mL streptomycin. 120 
 121 
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 8
Reagents. Z-VAD-FMK and Q-VD-OPh were purchased from Enzo Life 122 
Sciences or R & D Systems, Necrostatin-1 was purchased from Calbiochem. 123 
Ammonium chloride (AC), GuHCl, poly I:C, and human TNFα were purchased 124 
from Sigma-Aldrich. siRNAs were purchased from Dharmacon as SMARTpools 125 
of ON-TARGET plus siRNA. Non-targeting siRNA control pool or siRNA targeting 126 
β-galactosidase were used as controls. Antisera raised against reovirus were 127 
obtained from T. Dermody. Monoclonal antibody against IFNAR and rabbit 128 
antisera against RIP3 were purchased from Santa Cruz Biotechnology, those 129 
against TRIF, phospho-MLKL and total MLKL were purchased from Abcam, and 130 
those against RIG-I and MDA5 were purchased from Cell Signaling. Mouse 131 
antiserum specific for PSTAIR was purchased from Sigma, specific for KDEL 132 
was purchased from Enzo Life Sciences. Alexa Fluor-conjugated anti-mouse 133 
IgG, anti-rabbit IgG, and anti-goat IgG secondary antibodies were purchased 134 
from Invitrogen. IRDye-conjugated anti-guinea pig IgG was purchased from LI-135 
COR.  136 
 137 
Fixing, embedding, and sectioning of infected cells.  L929 cells grown on 100 138 
mm dishes were either mock infected or infected with 10 PFU/cell of T3D for 1 h 139 
at room temperature.  Following the viral attachment incubation, the cells were 140 
washed twice with PBS and then overlayed with fresh medium.  At 34 h post 141 
infection, uninfected and infected cells were washed with PBS, trypsinized, 142 
pelleted for 5 min at 800 ✕ g, and washed again with PBS.  The pelleted cells 143 
were then fixed with 2.5% glutaraldehyde diluted in sodium cacodylate buffer 144 
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 9
(100 mM sodium cacodylate [pH 7.5], 2 mM MgCl2, 2 mM CaCl2, 0.5% NaCl) for 145 
60 min at room temperature.  Following fixation, the cells were washed twice with 146 
sodium cacodylate buffer.  The washed cells were post fixed with 1% osmium 147 
tetroxide diluted in sodium cacodylate buffer for 60 min at room temperature.  148 
The fixed cells were washed twice with sodium cacodylate buffer followed by one 149 
wash with 100 mM sodium acetate [pH 4.2].  The cells were then stained with 150 
0.5% uranyl acetate diluted in 100 mM sodium acetate [pH 4.2] for 60 min at 151 
room temperature.  After staining, the cells were washed twice with 100 mM 152 
sodium acetate [pH 4.2].  Prior to embedding, the fixed and stained cells were 153 
dehydrated with sequential concentrations of ethanol (EtOH):  35% EtOH once 154 
for 5 min, 50% EtOH once for 5 min, 70% EtOH once for 5 min, 90% EtOH once 155 
for 5 min, 95% EtOH once for 5 min, and 100% EtOH four times for 5 min each.  156 
The dehydrated cells were incubated in a solution composed of 50% EMbed 812 157 
resin and 50% EtOH for 2 h at room temperature.  The cells were then incubated 158 
in 100% EMbed 812 resin overnight at room temperature.  The next day, the 159 
resin was replaced with fresh EMbed 812 resin, which was allowed to harden for 160 
18 h at 65°C.  Thin-sections (85 nm thick) were collected using a diamond knife 161 
on a Leica Biosystems microtome. 162 
 163 
Transmission electron microscopy (TEM).  Thin-sections of uninfected and 164 
infected cells were applied to 300-mesh copper grids and stained with Reynold’s 165 
lead citrate and 2% uranyl acetate (40).  The stained grids were analyzed using a 166 
JEOL 1010 transmission electron microscope operating at 80 kV.  Images were 167 
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 10
recorded using a Gatan MegaScan 794 charge-coupled-device camera.  168 
Micrographs were processed and analyzed using ImageJ software. 169 
 170 
Infections and preparation of extracts. Cells were either adsorbed with PBS or 171 
T3D at room temperature for 1 h, followed by incubation with media at 37ºC for 172 
the indicated time interval. Ribavirin, GuHCl, Z-VAD-FMK, Q-VD-OPh, 173 
Necrostatin-1, or anti-IFNAR Ab was added to the media immediately after the 1 174 
h adsorption period. For preparation of whole cell lysates, cells were washed in 175 
phosphate-buffered saline (PBS) and lysed with 1X RIPA (50 mM Tris [pH 7.5], 176 
50 mM NaCl, 1% TX-100, 1% DOC, 0.1% SDS, and 1 mM EDTA) containing a 177 
protease inhibitor cocktail (Roche), 500 μM DTT, and 500 μM PMSF, followed by 178 
centrifugation at 15000 × g for 10 min to remove debris. For detection of 179 
phosphorylated MLKL, cells were lysed in 1X RIPA supplemented with 10 mM 180 
NaF. 181 
 182 
RNA transfection and cell death. L929 cells were mock infected or infected 183 
with 10 PFU/cell of T3D for 24 h. Total RNA was extracted using Tri-reagent 184 
(Molecular Research Center). When needed, the RNA was mock treated or CIP 185 
treated for 1 h at 37°C and repurified using Tri-reagent. 100 ng of RNA was 186 
introduced into the cells by Lipofectamine 2000 transfection. Cell death was 187 
measured 21-24 h following transfection. 188 
 189 
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Immunoblot assay. Cell lysates were resolved by electrophoresis in 190 
polyacrylamide gels and transferred to nitrocellulose membranes. Membranes 191 
were blocked for at least 1 h in blocking buffer (PBS containing 5% milk or 2.5% 192 
BSA) and incubated with antisera against MLKL (1:2000), phosho-MLKL (1:750), 193 
RIP3 (1:1000), MAVS (1:1000), RIG-I (1:1000), MDA5 (1:1000), TRIF (1:1000), 194 
or PSTAIR (1:10000) at 4ºC overnight. Membranes were washed three times for 195 
5 min each with washing buffer (TBS containing 0.1% Tween-20) and incubated 196 
with 1:20000 dilution of Alexa Fluor conjugated goat anti-rabbit IgG (for RIP3, 197 
RIG-I, and MDA5), donkey anti-goat IgG (for RIP3), goat anti-mouse IgG (for 198 
KDEL and PSTAIR), or IRDye-conjugated anti-guinea pig IgG (for σNS) in 199 
blocking buffer. Following three washes, membranes were scanned using an 200 
Odyssey Infrared Imager (LI-COR).  201 
 202 
Knockdown of host proteins by siRNA. In 96-well plates, 0.25 μl 203 
Lipofectamine 2000 was used to transfect 15 pmoles of siRNA. Cells (1 × 104) 204 
were seeded on top of the siRNA-lipofectamine mixture. In 24-well plates, 0.75 μl 205 
Lipofectamine 2000 was used to transfect 45 pmoles of siRNA. Cells (5 × 104) 206 
were seeded on top of the siRNA-lipofectamine mixture. Virus infection was 207 
performed 48 h following siRNA transfection. 208 
 209 
Assessment of cell death by measuring cellular ATP levels. Cells (1 × 104) 210 
grown in black, clear-bottom 96-well plates were mock infected with PBS or 211 
adsorbed with 10 PFU/cell of T3D at room temperature for 1 h. Following 212 
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incubation of cells at 37°C for 42 h, ATP levels were assessed using the Cell 213 
titer-Glo assay system (Promega).  214 
 215 
Assessment of cell death by acridine orange ethidium bromide staining. 216 
Cells grown in 24-well plates or 96-well plates were adsorbed with the indicated 217 
amount of virus. Inhibitors were added immediately following adsorption. The 218 
percentage of dead cells after 48 h incubation was determined using AOEB 219 
staining as described (41). For identifying host regulators of cell death, cells were 220 
transfected with siRNA as described above and incubated for 48 h prior to 221 
infection with T3D. For each experiment, >250 cells were counted by a blinded 222 
researchers, and the percentage of isolated cells exhibiting orange staining (EB 223 
positivity) was determined by epi-illumination fluorescence microscopy using a 224 
fluorescein filter set on an Olympus IX71 microscope. < 5% of uninfected cells 225 
were EB positive following treatment with each inhibitor or siRNA. 226 
 227 
Assessment of cell death by IncuCyte automated cell imaging. Cells grown 228 
in 48-well plates were mock infected with PBS or adsorbed with the indicated 229 
amount of virus. Inhibitors were added immediately following adsorption in 230 
addition to 500 nM Sytox green. The cells were imaged over a time course of 48 231 
h. Values of Sytox positive cells per mm2 48 h following infection are shown. 232 
   233 
Assessment of caspase-3/7 activity. ATCC L929 cells (1 × 104) were seeded 234 
into black clear-bottom 96-well plates, adsorbed with 10 PFU/cell of reovirus in 235 
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serum-free medium at room temperature for 1 h. Following incubation of cells at 236 
37°C for 48 h, caspase-3/7 activity was quantified using the Caspase-Glo-3/7 237 
assay system (Promega). 238 
 239 
Assessment of viral yield. BMDMs in 24-well plates were adsorbed in triplicate 240 
with 50 PFU/cell of T3D for 1 h. Cells were washed once with PBS, and 241 
incubated for 0 h or 24 h. Cells were frozen and thawed twice prior to 242 
determination of viral titer by plaque assay. Viral yields were calculated according 243 
to the following formula: log10yield24h = log10(PFU/ml)24h - log10(PFU/ml)0h. 244 
 245 
RT-qPCR. RNA was extracted from infected cells at various time intervals after 246 
infection using Tri-reagent or an RNAeasy kit (Qiagen). For RT-qPCR, 0.5 to 2 247 
μg of RNA was reverse transcribed using random hexamers or gene specific 248 
primers using High Capacity cDNA Reverse Transcription Kit (Applied 249 
Biosystems).  A 1:10 dilution of the cDNA was subjected to PCR using SYBR 250 
Select Master Mix (Applied Biosystems). ΔCt values for each cDNA sample were 251 
calculated by subtracting Ct values of T3DS1, ZBP1, or IFNβ and Ct values for 252 
GAPDH. Fold increase in gene expression with respect to control sample 253 
(indicated in each figure legend) was measured using the ΔΔCt method (42).  254 
 255 
Statistical analysis. Statistical significance between experimental groups was 256 
determined using the unpaired t-test function of the Graphpad Prism software. 257 
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Statistical analyses for differences in gene expression by RT-qPCR were done 258 
on the ΔCt values. 259 
  260 
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RESULTS 261 
Reovirus-induces necroptosis. Upon ultrastructural evaluation of L929 cells 262 
infected with prototype reovirus strain Type 3 Dearing (T3D) 34 h following 263 
infection (a time point conducive for recovery and processing of dying cells for 264 
microscopy), we observed cells with normal nuclear morphology, the absence of 265 
apoptotic blebs, swelling of the cellular cytoplasm and early stages of disruption 266 
of the plasma membrane (Figure 1A). These features are not characteristic of 267 
apoptosis and suggested that reovirus may elicit an alternate form of cell death, 268 
such as necrosis. Cell death can be assessed by measurement of cellular ATP 269 
levels or by evaluating the permeability of cellular nuclei to DNA-staining vital 270 
dyes. These treatments do not distinguish between cell death by apoptosis or 271 
necrosis and therefore need to be coupled with pharmacologic blockade of 272 
molecules specifically involved in cell death pathways leading to apoptosis or 273 
necrosis (43). Consistent with the absence of apoptotic features, although 274 
pancaspase inhibitors Z-VAD-FMK or Q-VD-OPh abolish effector caspase 275 
activation in L929 cells infected with reovirus, they fail to block cell death (Figure 276 
1B and 1C) (30). Instead, cell death following reovirus infection of L929 cells 277 
exhibits features of necrosis and is diminished by Nec1, a RIP1 kinase inhibitor 278 
(30). The kinase activity of RIP1 can potentiate the activation of RIP3 to promote 279 
necroptosis (6). To determine if reovirus-induced cell death occurs via this 280 
mechanism, we assessed the capacity of reovirus to elicit necrosis in cells 281 
expressing reduced levels of RIP3 (Figure 1D). We found that in comparison to 282 
cells treated with control siRNA, treatment of cells with siRNAs against RIP3 283 
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 16
significantly decreased cell death (Figure 1E, 1F). The effect of RIP3 siRNA 284 
against reovirus-induced cell death matched the effect of RIP3 siRNA on 285 
necroptosis-inducing treatment of TNFα and Z-VAD-FMK (Figure 1G). These 286 
data indicate a role for RIP3 in the induction of cell death following reovirus 287 
infection. RIP3 can participate in the induction of both apoptosis and necroptosis 288 
(7, 44, 45). Because cell death following reovirus infection is unaffected by 289 
diminishment of caspase activity (Figure 1B,1C), these data suggest that reovirus 290 
induces RIP3-dependent necroptosis in L929 cells.   291 
 RIP3-dependent necroptosis requires the activation of the effector protein 292 
MLKL (13-23). MLKL is directly phosphorylated by RIP3 and MLKL 293 
phosphorylation is considered to be a hallmark of the activation of necroptosis 294 
signaling cascade (13, 46). To determine if reovirus infection leads to the 295 
activation of MLKL, we immunoblotted extracts from reovirus-infected cells using 296 
a phospho-MLKL antibody (Figure 1H). Our results indicate that MLKL is 297 
activated within 24 h following reovirus infection and remains activated until 48 h 298 
post infection, when a significant proportion of cells are undergoing cell death. 299 
The detection of this biochemical marker along with the genetic and 300 
pharmacologic experiments described above indicating that cell death is blocked 301 
by loss of RIP3 function but not of caspase function, meet the criteria to 302 
demonstrate that reovirus infection of L929 cells results in necroptosis (15).  303 
 304 
 Reovirus infects cells in a variety of tissues in newborn mice. Previous 305 
work on reovirus-induced apoptosis has utilized primary neurons or mouse 306 
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 17
embryo fibroblasts (MEFs) to evaluate cell death pathways in primary cells. Since 307 
both neurons and MEFs succumb to reovirus via apoptosis (47-54), we used 308 
bone marrow-derived macrophages (BMDMs) to determine whether reovirus can 309 
induce necroptosis in primary cells. While it is not known if cells within the bone 310 
marrow are infected in reovirus-infected animals, identification of primary cells 311 
that undergo necroptosis following reovirus infection would allow us to 312 
complement our siRNA studies with work in cells from mice genetically deficient 313 
in important regulators of necroptosis. We found that cell death following reovirus 314 
infection of BMDMs occurred in the absence of caspase activity (Z-VAD-FMK-315 
treated cells) or RIP1 kinase activity (Nec1-treated cells) but was diminished 316 
when the activity of caspases and RIP1 kinase were simultaneously blocked 317 
(Figure 2A). Consistent with this, cell death was not blocked by the genetic 318 
absence of RIP3 but was reduced by blockade of caspases in the absence of 319 
RIP3 (Figure 2B, 2C). Cells lacking both caspase-8 and RIP3 were also resistant 320 
to death following reovirus infection (Figure 2D). These data indicate that 321 
reovirus can induce necroptosis in BMDMs when apoptosis is blocked. These 322 
findings match previous work in other systems where necroptosis is evident 323 
when caspases have been rendered non-functional (55-57). 324 
 In the context of infection by other viruses, necroptosis is antiviral (2, 4-7). 325 
To determine if necroptosis affects replication of reovirus, we measured viral 326 
yield over 24 h of infection in wild-type and RIP3-deficient BMDMs in the 327 
presence and absence of Z-VAD-FMK. Viral yields in wild-type cells treated with 328 
DMSO or Z-VAD-FMK were ~ 1 log10 (Figure 2E). The genetic absence of RIP3 329 
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enhanced viral yield to ~ 1.7 log10. Importantly, viral yield did not change in RIP3-330 
deficient BMDMs in conditions where apoptosis was blocked using Z-VAD-FMK. 331 
While the basis for the slight increase in viral yield in absence of RIP3 is unclear 332 
and was not further investigated, our data suggest that the capacity of cells to 333 
undergo necroptosis does not influence viral yield in cell culture. These data are 334 
reminiscent of previous evidence indicating that blockade of apoptosis does not 335 
influence reovirus replication in cell culture (47, 48). The absence of effect of cell 336 
death on reovirus replication in cell culture may be due to the differences in 337 
timing of the reovirus replication cycle and the induction of cell death. Whereas 338 
reovirus completes its replication cycle in 18 h, cell death following infection is 339 
not detected until 36-48 h following infection. 340 
  341 
Transfection of reovirus RNA can elicit necroptosis. Reovirus strains that 342 
exhibit a greater level of gene expression are more potent inducers of necrosis 343 
(58). Blockade of reovirus + strand RNA synthesis using ribavirin blocks necrosis, 344 
suggesting a possible role for viral RNA in the induction of necrosis (58). 345 
Transfection of dsRNA mimic poly I:C in L929 cells treated with either type I or 346 
type II IFNs results in cell death by necrosis (25, 26, 59). Because our data 347 
suggested a role for reovirus RNA in the induction of necroptosis in infected cells, 348 
we sought to determine if viral RNA was sufficient for the induction of 349 
necroptosis. For these experiments, we purified total RNA from mock- or 350 
reovirus-infected cells 24 h following infection. We found that in comparison to 351 
RNA from mock-infected cells, RNA extracted from T3D-infected cells induced a 352 
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significantly greater amount of cell death following transfection into cells (Figure 353 
3A, 3B). Cell death by transfected RNA was diminished by treatment with Nec1 354 
but not Q-VD-OPh (Figure 3C), analogous to what we have reported in L929 355 
cells infected with reovirus (30). These data are also consistent with previous 356 
work indicating that poly I:C-induced cell death is blocked by Nec1 (26). Our 357 
results presented above suggest that RNA isolated from reovirus-infected cells 358 
elicits necroptosis following introduction into L929 cells. Interestingly, unlike 359 
previous work with transfection of dsRNA into cells (25, 59), cell death following 360 
transfection of RNA extracted from reovirus-infected cells did not require priming 361 
of the cells with exogenous IFN. 362 
 We reasoned that necroptosis was induced without addition of exogenous 363 
IFN because transfection of reovirus RNA obtained from infected cells can 364 
induce the expression of IFNβ (60-62)(Figure 3D). Indeed, treatment with an 365 
IFNAR-blocking antibody MAR1-5A3 (63), resulted in a reduction in cell death 366 
(Figure 3D). IFNβ production following transfection of reovirus RNA occurs via 367 
RIG-I-mediated detection of the RNA (60). Consistent with this, removal of the 5’ 368 
phosphates using CIP resulted in a reduction in the expression of IFNβ (Figure 369 
3E) and the induction of cell death (Figure 3F, 3G). Interestingly, if cells were 370 
primed with exogenous IFNβ before transfection, the capacity of CIP-treated 371 
RNA to elicit necroptosis was restored (Figure 3F, 3G). These data suggest that 372 
though RIG-I mediated detection of viral RNA is required for IFNβ production, it is 373 
not sufficient for the induction of cell death. Thus, cell death induction occurs by 374 
sensing of viral RNA via an alternate pathway. 375 
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 Based on the evidence that poly I:C elicits necroptosis by TLR3 detection 376 
and signaling to RIP3 via TRIF (25, 26), we examined whether reovirus RNA-377 
induced necroptosis could be blocked by treatment of cells with ammonium 378 
chloride (AC), an agent that blocks TLR3-mediated detection of dsRNA (64). We 379 
found that though AC did not negatively impact IFNβ expression following RNA 380 
transfection (Figure 3H), it blocked cell death induction by transfected RNA 381 
(Figure 3I). Consistent with previous work, these data indicate that detection of 382 
reovirus RNA via RIG-I produces IFNβ. In addition, these data suggest that IFNβ 383 
primes reovirus RNA transfected cell to undergo TLR3-dependent necroptosis. 384 
Thus, the IFN- and TLR3-dependent pathway for induction of necroptosis 385 
following transfection of reovirus RNA into L929 cells is similar to that previously 386 
described for transfection of synthetic dsRNA (25, 59). 387 
 388 
Sensing of reovirus RNA during infection is required for necroptosis. We 389 
next sought to determine if detection of viral RNA in infected cells contributes to 390 
cell death induction in reovirus-infected cells. During infection, reovirus RNA can 391 
be detected by both RIG-I-like receptors (RLRs), RIG-I and MDA5 (65). 392 
Simultaneous reduction of both RLRs, or their common downstream signaling 393 
adaptor, MAVS, led to a significant reduction in cell death following reovirus 394 
infection (Figure 4A, 4B, 4C). The susceptibility of cells to TNFα and Z-VAD-FMK 395 
induced necroptosis was not changed following MAVS knockdown indicating that 396 
MAVS is not required for the function of the core necroptosis machinery (Figure 397 
4D). BMDMs deficient in either both RLRs or MAVS were also protected from 398 
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reovirus-induced necroptosis (Figure 4E, 4F). These data suggest that 399 
necroptosis following reovirus infection requires detection and signaling by RLRs.  400 
 401 
IFN signaling is required for necroptosis. To determine whether type I IFNs 402 
produced by RLR-MAVS signaling are required for reovirus-induced necroptosis, 403 
we quantified the capacity of reovirus to induce necroptosis in the presence of an 404 
IFNAR-blocking antibody (63). We found that this antibody diminished the 405 
expression of a representative interferon-stimulated gene (ISG), ZBP1, which is 406 
potently induced following reovirus infection (66), and diminished the capacity of 407 
reovirus to induce necroptosis (Figure 5A, 5B, 5C). This reduction in necroptosis 408 
was not due to a deleterious effect of the antibody on the capacity of reovirus to 409 
establish infection (Figure 5D). Blocking IFNAR signaling did not alter the 410 
capacity of TNFα and Z-VAD-FMK cotreatment to induce necroptosis, suggesting 411 
that this treatment did not affect the function of the core necroptosis machinery 412 
(Figure 5E). IFNAR-deficient BMDMs treated with Z-VAD-FMK also were 413 
resistant to reovirus-induced necroptosis (Figure 5E, 5F), indicating a role for IFN 414 
signaling in the induction of necroptosis following reovirus infection. 415 
 Based on the role for TLR3 in necroptosis following transfection of RNA 416 
obtained from reovirus-infected cells (Figure 3), we next sought to evaluate 417 
whether TLR3 is also required for cell death in reovirus-infected cells. Toward 418 
this goal, we tested the effect of AC on cell death induction in reovirus-infected 419 
cells. Because treatment of cells with AC prevents reovirus infection by blocking 420 
capsid disassembly, we initiated infection of AC-treated cells with infectious 421 
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subvirion particles (ISVPs), a viral entry intermediate that bypasses the inhibitory 422 
effect of AC (67).  We found that necroptosis following infection by ISVPs was 423 
unaffected by treatment with AC (Figure 5G). Parallel transfection of cells with 424 
reovirus RNA in control and AC treated cells yielded results that matched those 425 
described in Figure 3H (data not shown), indicating that AC treatment was 426 
effective. siRNA-mediated reduction in the expression of TRIF, the TLR3 adaptor 427 
also did not block cell death following reovirus infection (Figure 5H, 5I). These 428 
data indicate that although RLR-mediated IFNβ expression and signaling is 429 
required for necroptosis following both, RNA transfection and viral infection, 430 
TLR3-mediated signaling is only required for cell death after viral RNA 431 
transfection. 432 
  433 
 Two-stage detection of reovirus infection is required for necroptosis.  434 
We next sought to determine the stage of infection required for the induction of 435 
necroptosis. Blockade of viral + strand RNA synthesis using ribavirin diminishes 436 
reovirus-induced necrosis (58). The reovirus + sense RNA can direct protein 437 
synthesis or can be packaged into progeny core particles and serve as the 438 
template for minus strand RNA synthesis to generate viral genomic dsRNA (68). 439 
Progeny cores containing genomic dsRNA undergo secondary transcription to 440 
produce additional viral mRNAs. Thus, the diminishment of necroptosis by 441 
ribavirin treatment may be due to blockade of any of these steps in reovirus 442 
replication. To define the stage of infection required for necroptosis further, we 443 
used Guanidine hydrochloride (GuHCl). GuHCl does not affect reovirus + strand 444 
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RNA synthesis but prevents the generation of genomic dsRNA within infected 445 
cells (Figure 6A, 6C)(69). Under the conditions used, perhaps because sufficient 446 
translation occurs from primary transcripts, we did not observe a diminishment in 447 
viral protein synthesis in the presence of GuHCl (Figure 6B). Treatment of 448 
reovirus-infected cells with GuHCl led to diminishment in necroptosis (Figure 6D, 449 
6E). Because GuHCl does not affect necroptosis induced by TNFα and Z-VAD-450 
FMK treatment (Figure 6F), our results point to the importance of the synthesis of 451 
viral genomic dsRNA for the induction of necroptosis following reovirus infection. 452 
 It is not known when during infection reovirus RNA is detected to produce 453 
IFNβ. The type of reovirus RNA that activates the expression of IFNβ in the 454 
context of infection also remains undefined. Ribavirin and GuHCl may thus 455 
indirectly prevent cell death because they affect the synthesis of RNA required 456 
for IFNβ synthesis. To better understand the effect of ribavirin and GuHCl on 457 
reovirus-induced cell death, we measured the expression of the IFNβ mRNA at 458 
different times following infection of L929 cells with reovirus. We observed a ~ 10 459 
fold increase in IFNβ mRNA levels 12 h following infection (Figure 7A). No further 460 
increase in IFNβ mRNA was observed at 18 or 24 h following infection. We found 461 
that though IFNβ mRNA expression was diminished by blockade of virus 462 
disassembly using AC, it was not decreased by either ribavirin or GuHCl 463 
treatment (Figure 7B). Although UV-inactivated virus failed to produce detectable 464 
levels of reovirus S1 + strand RNA (> 3 log10-fold reduction), it remained capable 465 
of eliciting the same level of IFNβ mRNA expression as control, infectious virus 466 
(Figure 7C, 7D). These data suggest that genomic RNA present within incoming 467 
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viral particles is sufficient for the induction of IFNβ expression. These results are 468 
consistent with data describing IFN induction by a UV inactivated reovirus 469 
mutant, IRF3 activation following reovirus infection in absence of RNA synthesis 470 
and recent studies on IFN expression following avian reovirus infection (49, 70, 471 
71). We observed that an infection-induced increase in IFNβ expression was 472 
diminished in cells transfected with MAVS siRNA (Figure 7E). Importantly, MAVS 473 
was also required for efficient induction of IFNβ expression in reovirus-infected 474 
cells when viral + strand RNA synthesis was blocked using ribavirin (Figure 7E). 475 
These data suggest that genomic RNA within incoming virus particles is detected 476 
by cytoplasmically localized RLRs and signals via MAVS to produce IFNβ. 477 
Because necroptosis is blocked by GuHCl under conditions where IFNβ is 478 
produced but viral dsRNA synthesis is diminished (Figure 6, 7), these studies 479 
indicate that IFNβ signaling is required but not sufficient for the induction of cell 480 
death. Together, our data indicate a role for reovirus RNA at two different stages 481 
of infection to induce necroptosis. First, viral genomic dsRNA is detected during 482 
entry to activate type I IFN signaling. Second, generation of newly synthesized 483 
viral dsRNA is required for the induction of necroptosis.  484 
 o
n
 M
arch 15, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
 25
DISCUSSION 485 
In this manuscript, we demonstrate that reovirus infection of both cultured cells 486 
and primary murine macrophages evokes necroptosis. Our results point to a role 487 
for viral components at two stages of infection to evoke necroptosis (Figure 8). 488 
First, detection of the incoming viral genomic RNA by host cell cytoplasmic 489 
sensors to produce IFNβ is required for necroptosis (Figure 4). In addition, 490 
synthesis of new viral genomic dsRNA also is required for the induction of 491 
necroptosis (Figure 6). This work indicates that the type I IFN signaling pathway 492 
functions in the induction of necroptosis following infection by an RNA virus. 493 
These data provide evidence for a previously unknown signaling cascade by 494 
which infection with an RNA virus culminates in necroptosis. 495 
  IFN signaling has been previously implicated in the induction of 496 
necroptosis. In Salmonella typhimurium infected mice, murine macrophages 497 
undergo necroptosis (72). In this context, the IFNAR is internalized and 498 
complexes with RIP1 and RIP3 to elicit necroptosis (72). ISGF3, a protein 499 
complex that drives the expression of ISGs following IFN signaling is required for 500 
sustained activation of RIP3 following ligation of TNFR or TLRs (73). However, 501 
whether a particular ISG modulates the basal activity of RIP3 has not been 502 
defined. Multiple ISGs are implicated in the induction of necroptosis. These 503 
include ZBP1/DAI, which may sense either viral DNA, viral RNA, or viral proteins, 504 
and those that recognize viral dsRNA (TLR3 and PKR)(5, 25, 27, 28, 74). Based 505 
on the role of DAI in the induction of necroptosis following IAV infection (27, 28), 506 
we tested the contribution of DAI to reovirus induced cell death. We found that 507 
 o
n
 M
arch 15, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
 26
reovirus remained capable of inducing cell death in ZBP1-deficient BMDMs (data 508 
not shown). Our results suggest that TLR3 does not participate in necroptosis 509 
induction following reovirus infection (Figure 5). PKR can promote necroptosis in 510 
cells lacking functional FADD (74). Reovirus induces necroptosis in wild-type 511 
cells expressing FADD (Figure 1, 2). Moreover, because reovirus encodes a 512 
well-described PKR inhibitor, we think it unlikely that PKR is involved in this 513 
process (75). Thus, the identity of the ISGs that control necroptosis following 514 
reovirus infection remains to be determined. Because IAV induced necroptosis is 515 
unaffected by the genetic absence of MAVS or IFNAR (7) and requires ZBP1 516 
(27, 28), whereas reovirus-induced necroptosis requires MAVS and IFNAR 517 
(Figure 4, 5) but is not affected by the absence of ZBP1, the mechanism 518 
underlying necroptosis following reovirus infection appears distinct from that 519 
reported for IAV. 520 
  Investigations into reovirus-induced cell death indicate that reovirus 521 
infection can initiate cell death signaling from distinct stages of replication and 522 
elicit cell death via a variety of pathways. The precise pathway that executes cell 523 
death likely varies with cell type. One model suggests that events initiated during 524 
cell entry that occur after virus disassembly but prior to de novo synthesis of viral 525 
RNA and proteins can elicit cell death by apoptosis (76). Apoptosis by this 526 
mechanism is thought to occur independently of the presence of viral genomic 527 
RNA but relies on the function of the μ1 capsid protein and the host transcription 528 
factor NFκB (47, 77). Another set of studies implicates a role for viral genomic 529 
RNA, viral RNA sensors, and IRF3 in the induction of apoptosis. However, cell 530 
 o
n
 M
arch 15, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
 27
death by this pathway does not appear to require viral replication or type I IFN 531 
signaling (49, 78). Two BH3-only members of the Bcl-2 family, Bid and Noxa 532 
appear to be involved in the induction of apoptosis and their function is 533 
downstream of transcription factors NFκB and IRF3 (48, 78). Our studies 534 
presented highlight an additional way in which reovirus infection leads to cell 535 
death. First, distinct from previous work on reovirus-induced apoptosis, we show 536 
that IFN signaling is required for necroptosis. Though we have not directly tested 537 
its requirement, IRF3, which is required for IFNβ expression (79), likely also plays 538 
a role in necroptosis. Thus the requirement for IRF3 in reovirus induced 539 
apoptosis and necroptosis is likely shared. Unlike for apoptosis, we demonstrate 540 
that the generation of viral genomic dsRNA late in infection is required for 541 
necroptosis (Figure 5). The requirement for genomic dsRNA synthesis may be 542 
direct, similar to the detection of viral RNA during transfection (Figure 2). 543 
Alternatively, synthesis of genomic dsRNA may be required to produce 544 
secondary transcripts, which in turn are detected by the host cell to induce 545 
necroptosis. Secondary transcripts generated following reovirus infection are 546 
qualitatively different than primary transcripts, and therefore, it is possible that 547 
secondary transcripts are detected in a manner distinct from primary transcripts 548 
(80). Though our studies indicate that protein synthesis in absence of ongoing 549 
dsRNA synthesis is not sufficient for necroptosis induction (Figure 6), it remains 550 
possible that viral proteins modulate necroptosis following reovirus infection.  551 
 Studies thus far have indicated a pathogenic role for apoptosis in reovirus-552 
induced encephalitis and myocarditis (81). Cell death pathways in reovirus-553 
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infected animals are thought to be tissue specific but precisely how these cell 554 
death pathways differ in a tissue-specific manner has not been defined (82, 83). 555 
It is possible that in some cases, cell death via IFN-dependent pathways we have 556 
described in this study contribute to tissue injury. Due to its natural preference for 557 
infecting and killing transformed cells and its innocuousness to human adults, 558 
reovirus is currently in phase III clinical trials as a cancer therapeutic (84). The 559 
capacity of reovirus to elicit cell death via multiple mechanisms may therefore 560 
underlie its efficacy as an effective therapeutic.    561 
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FIGURE LEGENDS 567 
Figure 1. Reovirus-induces necroptosis in L929 cells. (A) L929 cells infected 568 
with 10 PFU/cell of T3D for 34 h were fixed, stained, and imaged using 569 
transmission electron microscopy. (B) Cell death in L929 cells 48 h following 570 
mock infection or infection with 10 PFU/cell of T3D and treatment with DMSO or 571 
Q-VD-OPh (20 μM) was assessed by Cell Titer Glo. Luminescence measurement 572 
in similarly treated, uninfected cells was considered to represent 100% viability. 573 
(C) Caspase-3/7 activity 48 h following infection of L929 cells with 10 PFU/cell of 574 
T3D and treatment with DMSO or Q-VD-OPh was assessed by a 575 
chemiluminescent enzymatic assay. Caspase activity in mock-infected cells was 576 
set to 1. Data are represented as relative caspase-3/7 activity in comparison to 577 
similarly treated, uninfected cells. *, P < 0.05 compared to cells treated with 578 
DMSO. (D, E, F, G) L929 cells were transfected with non-targeting siRNAs or 579 
siRNAs specific for RIP3 (D) Efficiency of knockdown was assessed by 580 
immunoblotting for RIP3 and PSTAIR loading control. (E) Cell death 48 h 581 
following mock infection or infection with 10 PFU/cell of T3D was assessed by 582 
Cell Titer Glo. Luminescence measurement in similarly treated, uninfected cells 583 
was considered to represent 100% viability. *, P < 0.05 compared to cells 584 
transfected with non-targeting siRNAs. (F) Cell death 48 h following infection with 585 
10 PFU/cell of T3D was assessed by AOEB staining. *, P < 0.05 compared to 586 
cells transfected with non-targeting siRNAs. (G) Cell death 3 h following 587 
treatment with TNFα and Z-VAD-FMK treatment was assessed by Cell Titer Glo. 588 
Luminescence measurement in similarly siRNA treated, DMSO treated cells was 589 
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considered to represent 100% viability. (H) Whole cell extracts from L929 cells 590 
infected with 10 PFU/cell of T3D at the indicated time points were immunoblotted 591 
for phosphorylated MLKL, total MLKL, and PSTAIR loading control.  592 
 593 
Figure 2. Reovirus can induce necroptosis in primary BMDMs. (A) BMDMs 594 
from wild-type mice were mock infected or infected with 50 PFU/cell of T3D in the 595 
presence of DMSO, Z-VAD-FMK (25 μM) or Nec1 (50 μM) or both inhibitors. Cell 596 
death 48 h following infection was assessed by Cell Titer Glo. Luminescence 597 
measurement in similarly treated, uninfected cells was considered to represent 598 
100% viability. *, P < 0.05 compared to DMSO treated cells. (B) BMDMs from 599 
wild-type (left panel) or RIP3 -/- (right panel) mice were mock infected or infected 600 
with 50 PFU/cell of T3D in the presence DMSO or Z-VAD-FMK (25 μM). Cell 601 
death 48 h following infection was assessed by Cell Titer Glo. Luminescence 602 
measurement in uninfected cells of the same genotype that were similarly treated 603 
was considered to represent 100% viability. *, P < 0.05 compared to DMSO 604 
treated cells of the same genotype. (C) BMDMs were infected with 50 PFU/cell of 605 
T3D in the presence DMSO or Z-VAD-FMK (25 μM). Cell viability was assessed 606 
by Sytox green staining. *, P < 0.05 compared to DMSO treated cells of the same 607 
genotype. (D) BMDMs from wild-type, RIP3 -/-, or Casp8 -/- x RIP3 -/- mice were 608 
infected with 50 PFU/cell of T3D. Cell death 48 h following infection was 609 
assessed by Cell Titer Glo. Luminescence measurement in mock-infected cells 610 
of the same genotype was considered to represent 100% viability. *, P < 0.05 611 
compared to wild-type cells.  (E) BMDMs from wild-type or RIP3 -/- mice were 612 
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infected with 50 PFU/cell of T3D in the presence or absence of Z-VAD-FMK (25 613 
μM). Virus yield 24 h following infection was measured using plaque assay.  614 
  615 
Figure 3. Reovirus RNA is sufficient for the induction of necroptosis. (A,B) 616 
L929 cells were transfected with 100 ng of RNA extracted from mock-infected or 617 
reovirus-infected cells. (A) Cell death 24 h following transfection was assessed 618 
by Cell Titer Glo. Luminescence measurement in untransfected cells was 619 
considered to represent 100% viability. *, P < 0.05 compared to cells transfected 620 
with RNA extracted from mock-infected cells. (B) Cell death 24 h following 621 
transfection of RNA was assessed by AOEB staining. *, P < 0.05 compared to 622 
cells transfected with RNA extracted from mock-infected cells (C) L929 cells 623 
were transfected with 100 ng of RNA extracted from mock infected or reovirus-624 
infected cells in the presence of DMSO, Q-VD-OPh (25 μM) or Nec1 (50 μM). 625 
Cell death 24 h following transfection was assessed by Cell Titer Glo. 626 
Luminescence measurement in similarly treated cells transfected with RNA from 627 
mock-infected cells was considered to represent 100% viability.  *, P < 0.05 628 
compared to cells transfected with DMSO treated cells transfected with the same 629 
type of RNA (D) L929 cells were transfected with 100 ng of RNA extracted from 630 
mock-infected or reovirus-infected cells. Levels of IFNβ mRNA were assessed by 631 
RT-qPCR at 18 h following transfection. IFNβ:GAPDH ratio for cells transfected 632 
with RNA from mock-infected cells was considered 1. *, P < 0.05 compared to 633 
cells transfected with RNA from mock-infected cells. (E) L929 cells were 634 
transfected with 100 ng of RNA extracted from mock-infected or reovirus-infected 635 
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cells in the presence and absence of 0.1 μg/ml anti-IFNAR Ab. Cell death 24 h 636 
following transfection was assessed by Cell Titer Glo. Luminescence 637 
measurement in similarly treated cells transfected with RNA from mock-infected 638 
cells was considered to represent 100% viability. *, P < 0.05 compared to cells 639 
transfected with same type of RNA without anti-IFNAR Ab. (F) L929 cells were 640 
transfected 100 ng of untreated or CIP-treated RNA extracted from reovirus-641 
infected cells. Levels of IFNβ mRNA were assessed by RT-qPCR at 18 h 642 
following transfection. IFNβ:GAPDH ratio for cells transfected with untreated 643 
RNA from reovirus-infected cells was considered 1. *, P < 0.05 compared to cells 644 
transfected with untreated RNA from reovirus-infected cells. (G) Cells treated 645 
with 0 or 100 units/ml IFNβ were transfected with 100 ng of untreated RNA from 646 
mock-infected cells or untreated or CIP-treated RNA from T3D-infected cells. Cell 647 
death 24 h following transfection was assessed by Cell Titer Glo. Luminescence 648 
measurement in similarly treated cells transfected with RNA from mock-infected 649 
cells was considered to represent 100% viability.  *, P < 0.05 compared to 650 
similarly treated cells transfected with untreated RNA from T3D-infected cells. **, 651 
P < 0.05 compared to cells transfected with similarly treated RNA in the presence 652 
of 0 units/ml of IFNβ. (H) Cells treated with 0 or 100 units/ml IFNβ were 653 
transfected with 100 ng of untreated or CIP-treated RNA from T3D-infected cells. 654 
Cell death 24 h following transfection of RNA was assessed by AOEB staining. *, 655 
P < 0.05 compared to cells transfected with similarly treated RNA in the presence 656 
of 0 mU/ml of IFNβ. (I) Cells pretreated with 0 or 20 mM AC were transfected 657 
with RNA from T3D-infected cells. Levels of IFNβ mRNA were assessed by RT-658 
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qPCR at 18 h following transfection. IFNβ:GAPDH ratio for cells 0 mM AC treated 659 
cells transfected with RNA from T3D-infected cells was considered 1. (J) Cells 660 
pretreated with 0 or 20 mM AC were transfected with 100 ng RNA from mock-661 
infected or T3D-infected cells. Cell death 24 h following transfection was 662 
assessed by Cell Titer Glo. Luminescence measurement in similarly treated cells 663 
transfected with RNA from mock-infected cells was considered to represent 664 
100% viability.  *, P < 0.05 compared to transfection of cells treated with 0 mM 665 
AC. 666 
 667 
Figure 4. Detection of viral RNA by cytoplasmic sensors is required for 668 
necroptosis. (A) L929 cells were transfected with non-targeting siRNAs or 669 
siRNAs specific for RIG-I, MDA5, or MAVS. Efficiency of knockdown was 670 
assessed by immunoblotting for RIG-I, MDA5, MAVS and KDEL or PSTAIR 671 
loading controls. (B, C, D) L929 cells were transfected with non-targeting siRNAs 672 
or siRNAs specific for both RIG-I and MDA5, or MAVS. (B) Cell death 48 h 673 
following mock infection or infection with 10 PFU/cell of T3D was assessed by 674 
Cell Titer Glo. Luminescence measurement in uninfected cells transfected with 675 
the same siRNA was considered to represent 100% viability. *, P < 0.05 676 
compared to cells transfected with non-targeting siRNAs. (C) Cell death 48 h 677 
following infection with 10 PFU/cell of T3D was assessed by AOEB staining. *, P 678 
< 0.05 compared to cells transfected with non-targeting siRNAs.  (D) Cell death 3 679 
h following treatment with TNFα and Z-VAD-FMK treatment was assessed by 680 
Cell Titer Glo. Luminescence measurement in similarly siRNA treated, DMSO 681 
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treated cells was considered to represent 100% viability. (E) Cell death in wild-682 
type, RIG-I -/- x MDA5 -/- or MAVS -/- BMDMs treated with Z-VAD-FMK following 683 
mock infection or infection with 50 PFU/cell of T3D was assessed by Cell Titer 684 
Glo. Luminescence measurement in mock-infected cells of the same genotype 685 
was considered to represent 100% viability. *, P < 0.05 compared to wild-type 686 
cells. (F) Cell death in wild-type, RIG-I -/- x MDA5 -/- or MAVS -/- BMDMs treated 687 
with Z-VAD-FMK (25 μM) following infection with 50 PFU/cell of T3D was 688 
assessed by Sytox green staining. *, P < 0.05 compared to wild-type cells. 689 
 690 
Figure 5. Signaling via IFNAR is required for necroptosis (A,B,C,D) L929 691 
cells were infected with 10 PFU/cell of T3D in the presence of 0.1 μg/ml of anti-692 
IFNAR Ab. (A) Levels of ZBP1 mRNA were assessed using RT-qPCR at 24 h 693 
post infection. ZBP1:GAPDH ratio at 0 h post infection was set to 1. *, P < 0.05 694 
compared to cells infected without IFNAR antibody. (B) Cell death 48 h following 695 
mock infection or infection with 10 PFU/cell of T3D was assessed by Cell Titer 696 
Glo. Luminescence measurement in similarly treated, mock-infected cells was 697 
considered to represent 100% viability. *, P < 0.05 compared to cells infected 698 
without IFNAR antibody. (C) Cell death 48 h following infection with 10 PFU/cell 699 
of T3D was assessed by AOEB staining. *, P < 0.05 compared to cells infected 700 
without IFNAR antibody. (D) Viral infectivity 18 h following infection with 2 701 
PFU/cell T3D was assessed by indirect immunofluorescence. (E) Cell death 3 h 702 
following treatment with TNFα and Z-VAD-FMK treatment was assessed by Cell 703 
Titer Glo. Luminescence measurement cells treated without IFNAR antibody was 704 
 o
n
 M
arch 15, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
 36
considered to represent 100% viability. (F) Cell death in wild-type and IFNAR-705 
deficient BMDMs treated with Z-VAD-FMK following mock infection or infection 706 
with 50 PFU/cell of T3D. Cell viability was assessed by Cell titer Glo. 707 
Luminiscence measurement in mock-infected cells of the same genotype was 708 
considered to represent 100% viability. *, P < 0.05 compared to wild-type cells. 709 
(G) Cell death in wild-type and IFNAR-deficient BMDMs treated with Z-VAD-FMK 710 
following infection with 50 PFU/cell of T3D was assessed by Sytox green 711 
staining. *, P < 0.05 compared to wild-type cells. (H) L929 cells were mock 712 
infected or infected with 100 PFU/cell of T3D ISVPs in the presence or absence 713 
of 20 mM AC. Cell death 48 h following infection was assessed by Cell Titer Glo. 714 
Luminiscence measurement in similarly treated, mock-infected cells was 715 
considered to represent 100% viability.  *, P < 0.05 compared to cells infected 716 
without AC. (H, I) L929 cells were transfected with non-targeting siRNAs or 717 
siRNAs specific for TRIF. (H) Efficiency of knockdown was assessed by 718 
immunoblotting for TRIF and PSTAIR loading control. (I) Cell death 48 h 719 
following mock infection or infection with 10 PFU/cell of T3D was assessed by 720 
Cell Titer Glo. Luminescence measurement in uninfected cells transfected with 721 
the same siRNA was considered to represent 100% viability.  722 
 723 
Figure 6. Synthesis for genomic dsRNA is required for necroptosis. L929 724 
cells were infected with 10 PFU/cell of T3D in the presence of ribavirin (200 μM) 725 
or GuHCl (15 mM). (A) Levels of reovirus + strand RNA corresponding to the viral 726 
S1 gene segment were measured by RT-qPCR 24 h post infection. Reovirus 727 
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T3D S1 +:GAPDH ratio in untreated cells infected for 0 h was considered 1.*, P < 728 
0.05 compared to cells infected with T3D in absence of inhibitor. (B) Levels of 729 
reovirus μ1C protein and PSTAIR loading control 24 h following infection with 10 730 
PFU/cell of T3D were assessed by immunoblotting. (C) Generation of reovirus 731 
genomic dsRNA at 24 h following infection was evaluated by electropherotyping. 732 
(D) Cell death 48 h following mock infection or infection with 10 PFU/cell of T3D 733 
was assessed by Cell Titer Glo. Luminescence measurement in similarly treated, 734 
uninfected cells was considered to represent 100% viability. *, P < 0.05 735 
compared to control treated cells. (E) Cell death 48 h following infection with 10 736 
PFU/cell of T3D was assessed by AOEB staining. *, P < 0.05 compared to 737 
control treated cells. (F) Cell death 4 h following treatment with TNFα and Z-738 
VAD-FMK treatment was assessed by Cell Titer Glo. Cell viability in similarly 739 
treated cells in absence of TNFα and Z-VAD-FMK was considered 100%. 740 
 741 
Figure 7. De novo synthesis of viral RNA is not required for IFN expression. 742 
(A) L929 cells were infected with 10 PFU/cell of T3D. Levels of IFNβ mRNA were 743 
assessed at the indicated time intervals using RT-qPCR. IFNβ:GAPDH ratio at 0 744 
h post infection was set to 1. *, P < 0.05 compared to cells infected for 0 h. (B) 745 
L929 cells treated with AC (20 mM), ribavirin (200 μM), or GuHCl (15 mM) were 746 
infected with 10 PFU/cell of T3D. Levels of IFNβ mRNA were assessed by RT-747 
qPCR at 24 h post infection. IFNβ:GAPDH ratio for untreated, T3D-infected cells 748 
was set to 1. *, P < 0.05 compared to control treated, infected cells. (C,D) L929 749 
cells were infected with 10 PFU/cell of T3D and equivalent particles of UV-750 
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treated T3D. (C) Levels of reovirus + strand RNA corresponding to the viral S1 751 
gene segment were measured by RT-qPCR 24 h post infection. Reovirus T3D 752 
S1 +:GAPDH ratio in cells infected for 0 h was considered 1. UD, undetectable, 753 
value below that detected at 0 h (D) Levels of reovirus IFNβ RNA corresponding 754 
were measured by RT-qPCR 24 h post infection. IFNβ:GAPDH ratio in cells 755 
infected with infectious T3D was considered 1. (E) L929 cells were transfected 756 
with non-targeting siRNAs or siRNAs specific for MAVS. Levels of IFNβ mRNA in 757 
cells infected with 10 PFU/cell of T3D in the presence of absence of ribavirin 758 
(200 μM) were assessed by RT-qPCR. IFNβ:GAPDH ratio for untreated, T3D 759 
infected non-targeting siRNA treated was set to 1. *, P < 0.05 compared to 760 
untreated, T3D infected non-targeting siRNA treated cells.  761 
  762 
Figure 8. Model for reovirus-induced necroptosis. Genomic RNA from 763 
incoming viral particles is sensed by RLRs to produce type I IFN in a MAVS-764 
dependent manner. De novo synthesized viral genomic dsRNA or viral 765 
secondary transcripts produced from newly synthesized genomic dsRNA (GuHCl 766 
sensitive replication events) are detected by an as yet unidentified ISG to elicit 767 
RIP3-dependent necrotic cell death.   768 
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